• Info
  • Insider Ownership

Insider Trading & Ownership of Mark C. McKenna

Location
Bridgewater, NJ
Summary
The estimated net worth of Mark C. McKenna is at least $1,682,105 dollars as of 09 Jan 2026. Mark C. McKenna is the Director of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $997K. Mark C. McKenna is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $363.6K. Mark C. McKenna is the Former Director of BridgeBio Oncology Therapeutics, Inc. and owns shares of Helix Acquisition Corp. II (HLXB) stock worth about $321.5K.
Signature
/s/ Louise Kooij by Power of Attorney from Mark C. McKenna
All Insider Reports
All Insider Reports

Notify me when Mark C. McKenna files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Mark C. McKenna

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APGE Apogee Therapeutics, Inc. Director $997,000 17 Jun 2025
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director $363,586 07 Jan 2026
HLXB Helix Acquisition Corp. II Former Director $321,519 11 Aug 2025
PCSC Perceptive Capital Solutions Corp Director 11 Jun 2024
RXDX Prometheus Biosciences, Inc. Chairman, President and CEO, Director 16 Jun 2023
SYRE Spyre Therapeutics, Inc. Director 29 May 2025

Insider Transactions Reported by Mark C. McKenna:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.